tions within a survey instrument that are intended to measure the same concept. The SF-12 has been validated in patients with heart disease, 15 human immunodeficiency virus, 7 severe mental illness, 23 heart failure, 3 strokes, 15 retinal disease, 9 lower limb amputation, 5 ankylosing spondylitis, 10 and low-back pain, 16 and in older adults, 22 however, little is known about the usefulness of the SF-12 in patients with cerebral aneurysms. In this study we used the SF-12 to measure health status in a population of patients with cerebral aneurysms, and assessed the construct validity and the internal consistency reliability of the instrument.
Clinical Material and Methods

Data Collection
We surveyed patients with aneurysms who had been recruited between June 2001 and February 2004 from the neurosurgical clinic at the University of Pittsburgh Medical Center. Informed consent was obtained from all patients before data acquisition, and the research protocol was approved by the institutional review boards of the University of Pittsburgh and Yale University. All patients underwent a structured interview administered by a trained research assistant and completed written and computerized surveys that collected data on demographics, symptoms, medical history, habits, health status, functional status, and mental health. Information on aneurysm characteristics and treatments were abstracted from the patients' medical records.
Health Status-the SF-12
Patients completed a written version of the SF-12 and standard scoring algorithms were used to score their responses to the 12 multiple-choice questions. 26 Scores for the SF-12 PCS and MCS summary scales can range from 0 to 100. The US population mean score is 50 and the corresponding SD is 10; higher scores indicate a better health state.
Functional Status-the GOS, mRS, and Barthel Index
Patient interview responses and a computerized scoring algorithm were used to classify patients on the basis of the GOS 13 and the mRS, 8, 21 and to calculate the Barthel index. 17 The GOS classifies patients into one of five categories: Score 5, good recovery (resumption of normal life despite deficits); Score 4, moderate disability (disabled but independent); Score 3; severe impairment (conscious but disabled); Score 2, persistent vegetative state; and GOS Score 1, death. The mRS categorizes patients into six classes: Score 0, no neurological symptoms or disabilities; Score 1, no disabilities despite neurological symptoms; Score 2, slight disability (unable to perform all activities of daily living); Score 3, moderate disability (walks without assistance); Score 4, severe disability (unable to walk without assistance); Score 5, bedridden; and Score 6, death. The Barthel Index combines scores for several activities of daily living to produce a score (index) ranging from 0 to 20 with higher scores representing better functioning.
Mental Health-HAD Scale
Patients completed the HAD Scale, a 14-item self-administered written survey instrument used to measure anxiety and depression. 29 For each item, patients selected one of four graded responses to a statement (for example, "I feel as if I am slowed down: _ Nearly all of the time, _ Very often, _ Sometimes, _ Not at all.)". Half of the items are used to assess depression and the remainder to assess anxiety; depression and anxiety items alternate throughout the survey. Each item response was scored from 0 to 3; responses were summed to produce anxiety and depression scores ranging from 0 to 21, with higher scores corresponding to greater levels of anxiety or depression.
Statistical Analysis
Study population means, SDs, medians, and quartiles were calculated for continuous variables, and categorical variables were tabulated. Health status and functional status SF-12 scores in the aneurysm cohort were compared with age and sex-adjusted US population normative values by performing the Student t-test with the Satterthwaite approximation for unequal variances. The relationship between subgroups (SAH, unsecured versus obliterated aneurysms, and prior surgery) and health status (PCS and MCS) or functional status (GOS score, mRS score, and Barthel Index) was examined using the Mann-Whitney U-test 18 supplemented with exploratory regression analyses. Construct validity was assessed by determining whether the SF-12 scores varied in accordance with predefined hypotheses. Specifically, we hypothesized that PCS scores would increase with better scores on the GOS and mRS, and a better Barthel Index. We used the Cuzick nonparametric test for 119 (70) * There were 240 aneurysms in the study population. trend 6 to assess the SF-12 scores across categories of the GOS and mRS, and the Spearman rho correlation coefficient 24 to compare SF-12 scores with continuous Barthel indices. We also hypothesized that MCS scores would increase with lower levels of depression and anxiety measured with the HAD Scale. We used the Spearman rho to assess MCS scores as opposed to HAD Scale scores. The reliability Cronbach alpha statistic was used to assess interitem reliability (the correlation between questions within a survey instrument that are intended to measure the same concept) on the SF-12 by using the Nunnally criterion of 0.7.
20 Two-tailed probability values less than 0.05 were considered statistically significant.
Results
Study Population
Two-hundred seventeen eligible patients consented to participate in the study. One hundred seventy (78%) completed the SF-12, and provided sufficient data to permit scoring of the GOS, mRS, and Barthel Index. Incomplete data collection was caused by errors in survey completion, research staffing issues, and patient time constraints. Details of the study population are given in Table 1 . The mean patient age was 53.5 Ϯ 12.9 years (mean Ϯ SD), and the study population was predominantly female (72%) and caucasian (93%). Most patients harbored one aneurysm (72%) and the majority of aneurysms were located in the anterior circulation (85%). Fifty-four percent of patients had experienced an SAH, 56% harbored an unsecured aneurysm at risk for rupture, and 70% had undergone previous surgical or endovascular treatment for an aneurysm.
Health Status
The SF-12 scores were calculated for the PCS and MCS summary scales (Table 2) . When adjusted for differences in age and sex and compared with US normative data, patients with aneurysms had worse PCS and MCS scores (p Ͻ 0.001 for all). An examination of subgroups within the aneurysm study population showed that patients with a history of SAH had worse PCS scores than patients with no history of aneurysm rupture (p = 0.006). A history of SAH did not affect the MCS scores (p = 0.655). Patients with unsecured aneurysms had PCS and MCS scores similar to patients in whom all aneurysms had been obliterated (p Ն 0.108 for all). Patients who had previously undergone surgical clipping or endovascular embolization had significantly lower PCS scores (p = 0.047), but had similar MCS scores (p = 0.331) compared with patients without a history of aneurysm treatment. Linear regression models used to explore patient and aneurysm characteristics and functional status, while adjusting for MCS scores, showed that previous SAH and the mRS score were the only statistically significant predictors of PCS scores (F Ͻ 0.001, r 2 = 0.36). Similar models adjusting for PCS scores showed that the mRS score was the only significant predictor of MCS scores (F = 0.001, r 2 = 0.27).
Functional Status
Patients were assigned scores on the GOS, mRS, and Barthel Index based on self-reported activities of daily living (Fig. 1) . The study cohort was recruited from patients well enough to travel to a neurosurgery clinic and thus patients with lower levels of functioning were underrepresented in the analyses. Fully 80% of patients had a good recovery (GOS Score 5), 72% had no significant disability regardless of whether they had deficits (mRS Score 0 or 1), and 78% had no difficulties with any activities of daily living (Barthel index 20). There were minimal differences in the cohort's functional status attributable to SAH. Patients with a history of SAH had lower scores on the GOS (Table  3 ; p = 0.020), but no differences in mRS score (p = 0.370) or Barthel index (p = 0.103). Patients with unsecured aneurysms had similar scores when compared with patients in whom all aneurysms had been obliterated (p Ն 0.358 for all). Patients who had previously undergone surgical clip placement or endovascular embolization had virtually identical GOS, mRS, and Barthel Index functional statuses compared with patients without a history of aneurysm treatment (p Ն 0.205 for all).
Validity and Reliability
Validity of the SF-12. Most of the hypothesized relationships between the SF-12 scores and functional status measures were present, confirming the validity of the SF-12. The PCS scores were higher for better levels of functioning as measured using the GOS (p Ͻ 0.001) and mRS (p Ͻ 0.001), and there was a significant correlation between PCS scores and the Barthel index (Spearman = 0.33, p Ͻ 0.001) (Fig. 2a) . Better mental health, indicated by a higher MCS score, was associated with lower anxiety scores, measured using the HAD Scale (p = 0.001); however, there was no relationship between MCS scores and the HAD Scale depression score (p = 0.314; Fig. 2b) .
Reliability of the SF-12. The Cronbach alpha statistic for the SF-12 was 0.76, exceeding the Nunally criterion of greater than 0.70 as a threshold for inter-item reliability.
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Discussion
Cerebral aneurysms can affect health status by their rupture and stroke, symptomatic impingement on neural structures, treatment side effects, or psychological stress. Our current study demonstrates that patients with cerebral aneurysms have a decreased health status as measured by the SF-12, a generic health status instrument. Both physical and mental health are decreased in patients with aneurysms compared with US population norms. We examined several subgroups in our study population of 170 patients to assess the relationships between SF-12 scores and SAH, aneurysm status, and previous treatment. The subgroup with a history of SAH did have decreased physical health measured with the SF-12, but their mental health was unchanged. Previous open or endovascular surgery was associated with lower SF-12 PCS scores. The validity of the SF-12 was confirmed by finding the expected relationships between SF-12 scores and most functional status and mental health measures, and the reliability of the SF-12 in this population was demonstrated using the Cronbach alpha statistic.
The SF-12 is growing in popularity as an outcomes instrument for several reasons: 1) it is easily and quickly administered by a written or computerized survey; 2) it provides two outcomes measures summarizing physical and mental health; 3) the scale format (US population mean Score 50 with an SD of 10) allows for an easy comparison of the study population to norms; 4) detailed normative data stratified by sex, age, and comorbid conditions are available for more elaborate analyses; and 5) the SF-12 is a generic health status instrument, allowing the researcher to compare the study population with populations afflicted with other diseases because of the continual growth of SF-12 data in the literature. Outcomes instruments such as the SF-12 are developed in specific test populations. The usefulness and accuracy of an outcomes instrument is determined in part by its validity (how well it measures what it purports to measure) and its reliability (the consistency of its results when administered by different testers, at different times, in different locations, or across different test items that address similar concepts, that is, internal consistency). Even if an instrument is designed to be generic with broad applicability, one cannot assume that it is valid or reliable in a population other than the one used in the instrument's development. Of practical concern, if an instrument is not valid or reliable in a different population, test results may be false or misleading. To guard against erroneous results, outcomes instruments are assessed in the population of interest to establish their validity and reliability. The current study provides evidence for the validity and reliability of the SF-12 in patients with cerebral aneurysms.
In our study we used three measures of functional status: the GOS, the mRS, and the Barthel Index. The GOS has a long history as the most common outcomes measure used for patients with cerebral aneurysms. The GOS has many advantages: 1) virtually all neurosurgeons are familiar with the GOS; 2) scoring is straightforward and only requires assigning patients to one of five categories; and 3) GOS scores can often be determined during retrospective data collection. The outcomes categories of the GOS were designed for patients with head injuries, and thus may not be sensitive to the effects of aneurysmal disease. The Rankin scale was originally developed for use in rehabilitation patients, but this scale and its modification have been extended to patients with stroke and cerebral aneurysms in recent years. For example, some large cerebral aneurysm studies-the International Study of Unruptured Intracranial Aneurysms 11 and the International Study of Aneurysm Treatment 12 -rely on a modification of the Rankin scale as an outcomes measure. The Rankin scale has good interobserver agreement and reproducibility. 25, 28 The Barthel Index was designed to measure functional independence in longterm hospital patients with paralytic conditions and the effects of rehabilitation and treatment. It focuses on activities of daily living and relies on easily administered multiplechoice questions to provide a continuous scale response ranging from 0 to 20. Both the GOS and the Barthel Index had a significant ceiling effect in our population, with clustering of cases at the highest level of the scale. The mRS had a better dispersion of patients across its categories, which may explain why the regression analysis found that the mRS was better than either the GOS or the Barthel Index for predicting PCS and MCS scores.
Functional status is a component of health status, and thus we would expect systematic relationships between the GOS, mRS, and Barthel scores and the SF-12 PCS scores. The GOS, mRS, and Barthel Index provided a robust confirmation of the construct validity of the SF-12 PCS scale; as hypothesized, a higher PCS score corresponded to a higher level of functional status on all three scales. Our attempts to use the depression and anxiety scales generated by the HAD Scale to validate the MCS portion of the SF-12 met with mixed success. We did find the hypothesized relationship between higher MCS scores and lower HAD Scale anxiety scores; however, there was no relationship between MCS scores and HAD Scale depression scores. The HAD Scale may not be the best instrument with which to assess the validity of the SF-12 MCS because the HAD Scale is focused on depression and anxiety, whereas the MCS measures general mental health status. Few instruments are tested for or meet all aspects of validity (content, criterion, and construct validity) and reliability (test-retest and interrater reliability and internal consistency); the fulfillment of one aspect each of validity and reliability is generally sufficient.
The age, sex, and aneurysm distribution of our study population is representative of the epidemiology of cerebral aneurysms in North America. Patients with lower functioning were underrepresented in our sample because we were only able to study individuals who were well enough to travel to the neurosurgery clinic. Nevertheless, this study population (Rankin) . Within each category, the central horizontal line represents the median value, the box shows the interquartile range containing 50% of responses, the whiskers indicate values immediately adjacent to the interquartiles range, and the circles indicate outliers. The scatterplots demonstrate the distribution of health status scores compared with the continuous Barthel index. A better health status measured using SF-12 PCS scores corresponds to a better functional status measured using the GOS, mRS, and Barthel Index (a). An improved health status measured using SF-12 MCS scores corresponds to a better functional status measured using the GOS, mRS, and Barthel Index (b).
is representative of that seen by practicing vascular neurosurgeons in the outpatient setting and thus provides valuable insights for clinicians who treat patients with cerebral aneurysms.
Conclusions
We studied the health status of a large population of patients with cerebral aneurysms by using the SF-12, a popular generic health status instrument. The physical and mental health status of our study population, as measured by SF-12 scores, is significantly lower that that of the US population, even after adjusting for differences in age and sex. We found strong evidence that the SF-12 PCS is a valid instrument for use in patients with cerebral aneurysms. Our evidence for the validity of the SF-12 MCS is not as convincing; however, our failure to find consistent support for MCS validity may be attributable to shortcomings in the HAD Scale as a measure of construct validity.
